NASDAQ:MEDP
Medpace Holdings, Inc.
Medpace Holdings, Inc.'s revenue grew 20.0% in fiscal 2025 to $2.5B while operating margin fell to 21.1%. Free cash flow was $681.9M, 26.9% of revenue, and the diluted share count fell 7.8%.Summary generated from Medpace Holdings, Inc.'s SEC filings. Latest annual report filed Feb 10, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$2.5B
Revenue growth+20.0%
Revenue, 5-yr CAGR+22.3%
Gross marginn/a
Operating margin21.1%
Net margin17.8%
ROICn/a
Return on equity70.2%
Debt / equityn/a
Free cash flow$681.9M
FCF margin26.9%
Share count change−7.8%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1,142 | 1,460 | 1,886 | 2,109 | 2,530 |
| Operating income | 199 | 279 | 337 | 447 | 535 |
| Net income | 182 | 245 | 283 | 404 | 451 |
| Free cash flow | 235 | 351 | 397 | 572 | 682 |
Recent filings
- 4Insider transaction report
Oct 9, 2026 - 4Insider transaction report
Oct 2, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 23, 2026 - 8-KResults of operations and financial condition
Jul 22, 2026 - 8-KDirector or officer change
Jun 4, 2026 - 8-KAmendment to articles or bylaws
May 19, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
Apr 23, 2026 - 8-KResults of operations and financial condition
Apr 22, 2026